Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An infiltrating bladder transitional cell carcinoma exhibiting micropapillary growth pattern. -- 2003
2 clinical trials registered. Interventions under study include drug therapy, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE2, 1 EARLY_PHASE1. Research is primarily sponsored by academic and government institutions.
4 publications have been identified in PubMed for micropapillary variant infiltrating bladder urothelial carcinoma. Research spans Case Report / Case Series (25%), Clinical Trial Publication (25%), and Basic Science / Preclinical (25%).
Kraevska E (2025). [PMID: 41003151](https://pubmed.ncbi.nlm.nih.gov/41003151/). *Med Sci (Basel)*. [Basic Science / Preclinical]
Jojima K (2025). [PMID: 39758247](https://pubmed.ncbi.nlm.nih.gov/39758247/). *Cancer Diagn Progn*. [Clinical Trial Publication]
Portugal-Gaspar F (2024). [PMID: 39023556](https://pubmed.ncbi.nlm.nih.gov/39023556/). *Virchows Arch*. [Case Report / Case Series]
Agarwal S (2024). [PMID: 38846211](https://pubmed.ncbi.nlm.nih.gov/38846211/). *Cureus*. [Epidemiology / Natural History]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:35 PM UTC